1. Home
  2. CZWI vs GANX Comparison

CZWI vs GANX Comparison

Compare CZWI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Community Bancorp Inc.

CZWI

Citizens Community Bancorp Inc.

HOLD

Current Price

$17.96

Market Cap

158.1M

Sector

Finance

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$3.15

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZWI
GANX
Founded
1938
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.1M
159.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CZWI
GANX
Price
$17.96
$3.15
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.00
AVG Volume (30 Days)
28.4K
2.2M
Earning Date
01-26-2026
11-12-2025
Dividend Yield
2.01%
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$58,987,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.29
N/A
P/E Ratio
$13.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.69
$1.41
52 Week High
$18.74
$4.34

Technical Indicators

Market Signals
Indicator
CZWI
GANX
Relative Strength Index (RSI) 55.88 49.06
Support Level $17.98 $2.90
Resistance Level $18.49 $3.45
Average True Range (ATR) 0.29 0.48
MACD -0.09 -0.13
Stochastic Oscillator 16.18 46.59

Price Performance

Historical Comparison
CZWI
GANX

About CZWI Citizens Community Bancorp Inc.

Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: